• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌中单核苷酸多态性的格局

The Landscape of Single Nucleotide Polymorphisms in Papillary Thyroid Carcinoma.

作者信息

Kyrodimos Efthymios, Chrysovergis Aristeidis, Mastronikolis Nicholas, Papanastasiou George, Tsiambas Evangelos, Spyropoulou Despoina, Katsinis Spyros, Manoli Arezina, Papouliakos Sotirios, Pantos Pavlos, Ragos Vasileios, Peschos Dimitrios, Papanikolaou Vasileios

机构信息

First ENT Department, Hippocration Hospital, University of Athens, Athens, Greece.

ENT Department, Medical School, University of Patras, Patras, Greece.

出版信息

Cancer Diagn Progn. 2023 Jan 3;3(1):26-30. doi: 10.21873/cdp.10175. eCollection 2023 Jan-Feb.

DOI:10.21873/cdp.10175
PMID:36632585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9801452/
Abstract

Thyroid carcinoma represents a leading malignancy among those derived from human endocrine systems. It comprises a variety of different histological subtypes, including mainly papillary carcinoma, follicular carcinoma, anaplastic carcinoma, and medullar carcinoma. A broad spectrum of genetic imbalances, comprising gross chromosomal (polysomy/aneuploidy) and specific gene (mutations, amplifications, deletions) alterations, has been reported. Interestingly, the role of isolated, specific gene polymorphisms, especially of the single nucleotide polymorphism (SNP) type, in thyroid carcinoma is under investigation. SNPs are the most common genetic variations in the genome. The current molecular review focuses on the impact of specific SNPs on the biological behavior of papillary thyroid carcinoma in their carriers.

摘要

甲状腺癌是人类内分泌系统来源的主要恶性肿瘤之一。它包括多种不同的组织学亚型,主要有乳头状癌、滤泡状癌、未分化癌和髓样癌。据报道,存在广泛的基因失衡,包括染色体数目异常(多倍体/非整倍体)和特定基因(突变、扩增、缺失)改变。有趣的是,孤立的特定基因多态性,尤其是单核苷酸多态性(SNP)类型在甲状腺癌中的作用正在研究中。SNP是基因组中最常见的基因变异。当前的分子综述聚焦于特定SNP对其携带者甲状腺乳头状癌生物学行为的影响。

相似文献

1
The Landscape of Single Nucleotide Polymorphisms in Papillary Thyroid Carcinoma.甲状腺乳头状癌中单核苷酸多态性的格局
Cancer Diagn Progn. 2023 Jan 3;3(1):26-30. doi: 10.21873/cdp.10175. eCollection 2023 Jan-Feb.
2
The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update.基因多态性在分化型甲状腺癌中的作用:2023年更新
Biomedicines. 2023 Apr 2;11(4):1075. doi: 10.3390/biomedicines11041075.
3
Genetic mutations in thyroid carcinoma.甲状腺癌中的基因突变
Minerva Endocrinol. 2009 Mar;34(1):11-28.
4
The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.间变性甲状腺癌的基因组和转录组图谱:对治疗的启示
BMC Cancer. 2015 Dec 18;15:984. doi: 10.1186/s12885-015-1955-9.
5
Overview of the 2022 WHO Classification of Thyroid Neoplasms.2022 年世卫组织甲状腺肿瘤分类概述。
Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14.
6
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes.滤泡型甲状腺乳头状癌在青少年中表现为毒性结节:TSHR 和 Gsα 基因的共存多态性。
Thyroid. 2013 Feb;23(2):239-42. doi: 10.1089/thy.2012.0279.
7
Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.X射线修复交叉互补基因3(XRCC3)基因多态性与中国汉族人群甲状腺乳头状癌易感性的关联
Tumour Biol. 2016 Jan;37(1):979-87. doi: 10.1007/s13277-015-3882-4. Epub 2015 Aug 12.
8
Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.特定DNA修复基因和细胞周期调控基因的多态性与甲状腺乳头状癌风险的关系
Cancer Biomark. 2016 Jun 7;17(1):97-106. doi: 10.3233/CBM-160622.
9
Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.在高分化甲状腺滤泡性肿瘤的发生过程中,非整倍体和RAS突变是相互排斥的事件。
Clin Endocrinol (Oxf). 2007 Nov;67(5):706-11. doi: 10.1111/j.1365-2265.2007.02949.x. Epub 2007 Jul 25.
10
Somatic amplifications and deletions in genome of papillary thyroid carcinomas.甲状腺乳头状癌基因组中的体细胞扩增和缺失
Endocrine. 2015 Nov;50(2):453-64. doi: 10.1007/s12020-015-0592-z. Epub 2015 Apr 12.

引用本文的文献

1
Gene Polymorphisms (rs2070744 and rs1799983) and Differentiated Thyroid Cancer: Investigating Associations with Clinical Outcomes.基因多态性(rs2070744和rs1799983)与分化型甲状腺癌:探究与临床结局的关联
Int J Mol Sci. 2025 Jan 17;26(2):759. doi: 10.3390/ijms26020759.
2
Downregulation of LPAR1 Promotes Invasive Behavior in Papillary Thyroid Carcinoma Cells.LPAR1的下调促进甲状腺乳头状癌细胞的侵袭行为。
Cancer Inform. 2024 Sep 8;23:11769351241277012. doi: 10.1177/11769351241277012. eCollection 2024.
3
Polymorphisms of DNA Repair Genes in Thyroid Cancer.甲状腺癌中 DNA 修复基因的多态性。
Int J Mol Sci. 2024 May 30;25(11):5995. doi: 10.3390/ijms25115995.
4
The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update.基因多态性在分化型甲状腺癌中的作用:2023年更新
Biomedicines. 2023 Apr 2;11(4):1075. doi: 10.3390/biomedicines11041075.
5
The Role of NQO1 in Ovarian Cancer.NQO1 在卵巢癌中的作用。
Int J Mol Sci. 2023 Apr 25;24(9):7839. doi: 10.3390/ijms24097839.

本文引用的文献

1
Sweetened beverages are associated with a higher risk of differentiated thyroid cancer in the EPIC cohort: a dietary pattern approach.甜饮料与 EPIC 队列中分化型甲状腺癌风险升高相关:一种饮食模式方法。
Eur J Nutr. 2023 Feb;62(1):105-114. doi: 10.1007/s00394-022-02953-5. Epub 2022 Jul 30.
2
Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis.二甲双胍与甲状腺癌发病和预后的关系:系统评价和荟萃分析。
PLoS One. 2022 Jul 28;17(7):e0271038. doi: 10.1371/journal.pone.0271038. eCollection 2022.
3
Risk Factors for Anaplastic Thyroid Carcinoma: A Case Series From a Tertiary Referral Center for Thyroid Surgery and Literature Analysis.间变性甲状腺癌的危险因素:来自甲状腺手术三级转诊中心的病例系列及文献分析
Front Oncol. 2022 Jul 7;12:948033. doi: 10.3389/fonc.2022.948033. eCollection 2022.
4
Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects.甲状腺癌的靶向治疗:酪氨酸激酶抑制剂临床应用的当前挑战及不良反应的处理。
Front Endocrinol (Lausanne). 2022 Jul 8;13:860671. doi: 10.3389/fendo.2022.860671. eCollection 2022.
5
Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation.全外显子组测序鉴定了肾移植后尿路上皮癌的突变特征。
J Transl Med. 2022 Jul 21;20(1):324. doi: 10.1186/s12967-022-03522-4.
6
Cancer Effects of Low to Moderate Doses of Ionizing Radiation in Young People with Cancer-Predisposing Conditions: A Systematic Review.低剂量至中剂量电离辐射对有癌症易感条件的年轻人的癌症影响:系统评价。
Cancer Epidemiol Biomarkers Prev. 2022 Oct 4;31(10):1871-1889. doi: 10.1158/1055-9965.EPI-22-0393.
7
Integrative analysis of genomic and transcriptomic alterations of and in cancer.癌症中 和 的基因组和转录组改变的综合分析。
Open Biol. 2022 Jul;12(7):220068. doi: 10.1098/rsob.220068. Epub 2022 Jul 13.
8
Management of medullary carcinoma of the thyroid: a review.甲状腺髓样癌的治疗:综述。
J Int Med Res. 2022 Jul;50(7):3000605221110698. doi: 10.1177/03000605221110698.
9
Application of Immunohistochemistry in Papillary Thyroid Carcinoma.免疫组织化学在甲状腺乳头状癌中的应用。
Methods Mol Biol. 2022;2534:175-195. doi: 10.1007/978-1-0716-2505-7_13.
10
Single Nucleotide Polymorphisms in Papillary Thyroid Carcinoma: Clinical Significance and Detection by High-Resolution Melting.甲状腺乳头状癌中的单核苷酸多态性:高分辨率熔解检测的临床意义
Methods Mol Biol. 2022;2534:149-159. doi: 10.1007/978-1-0716-2505-7_11.